Levosimendan Reduces Lung Injury in a Canine Model of Cardiopulmonary Bypass

BACKGROUND AND OBJECTIVES: To explore the lung-protective effect of levosimendan (LS) during cardiopulmonary bypass in a canine model by determining the wet/dry weight (W/D) ratio of lung tissue, malonaldehyde (MDA) and superoxide dismutase (SOD) concentrations, and performing a histological evaluat...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Korean Circ J
Prif Awduron: Feng, Junbo, Liu, Haiyuan, Chen, Jiayi, Wang, Jiyuan, Liu, Zhuang, Ge, Shenglin
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: The Korean Society of Cardiology 2016
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4891605/
https://ncbi.nlm.nih.gov/pubmed/27275177
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4070/kcj.2016.46.3.402
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg